Asunto(s)
Humanos , Profilaxis Antibiótica , Antibacterianos/uso terapéutico , Complicaciones Posoperatorias/prevención & control , Infecciones Comunitarias Adquiridas/tratamiento farmacológico , Farmacorresistencia Microbiana , Enfermedades Cutáneas Infecciosas/tratamiento farmacológico , Endocarditis Bacteriana/tratamiento farmacológico , Infección de la Herida Quirúrgica/prevención & control , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Infecciones Urinarias/tratamiento farmacológico , Mucosa Bucal/microbiología , Tracto Gastrointestinal/microbiologíaRESUMEN
The authors treated with paromomycin 25 patients, with AIDS and cryptosporidiosis. The drug was given orally in a doses of 500 mg qid, for a period of 14 days. Tolerance was good, with just two cases of mild side-effects. Clinical improvement was obtained in 19 (76 per cent) patients. Parasitological cure, however, occurred only in a low percentage (25 per cent). In some cases where initial success was observed, recrudescence occurred after some weeks or few months, but with retreatment again clinical improvement was obtained. Even if it does not lead to frequent parasite eradication, the good clinical results and tolerance permit us to consider paromomycin one of the few drugs effective for the treatment of cryptosporidial diarrhea in AIDS patients. Studies with maintainance therapy are indicated.